PERAMPANEL

PERAMPANEL was reported 7728 times

PERAMPANEL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROGENIC PULMONARY OEDEMA 5 0.5000
1 OPITZ TRIGONOCEPHALY SYNDROME 3 0.5000
2 SLEEP RELATED HYPERMOTOR EPILEPSY 5 0.5000
3 NEW ONSET REFRACTORY STATUS EPILEPTICUS 36 0.3273
4 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 8 0.2581
5 GENERALISED ONSET NON-MOTOR SEIZURE 7 0.2121
6 EPILEPSIA PARTIALIS CONTINUA 8 0.1905
7 LIPIDS 3 0.1875
8 HAEMATURIA TRAUMATIC 12 0.1791
9 ORTHOSTATIC TREMOR 7 0.1667
10 CEREBRAL SALT-WASTING SYNDROME 16 0.1616
11 INTESTINAL ATRESIA 14 0.1296
12 RESPIRATORY RATE 6 0.1250
13 EPILEPTIC PSYCHOSIS 5 0.1220
14 POLYNEUROPATHY IDIOPATHIC PROGRESSIVE 8 0.1194
15 POSTICTAL PARALYSIS 27 0.1116
16 LOCOMOTIVE SYNDROME 4 0.1081
17 MULTIPLE-DRUG RESISTANCE 332 0.1070
18 VAGAL NERVE STIMULATOR IMPLANTATION 22 0.0719
19 DRUG CLEARANCE INCREASED 16 0.0717
20 SEIZURE CLUSTER 50 0.0603
21 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 32 0.0598
22 CATARACT CONGENITAL 10 0.0592
23 CORTICAL VISUAL IMPAIRMENT 3 0.0517
24 CORTICAL DYSPLASIA 3 0.0508
25 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 18 0.0474
26 POSTICTAL PSYCHOSIS 7 0.0449
27 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 29 0.0446
28 ATONIC SEIZURES 38 0.0442
29 PULMONARY HAEMORRHAGE NEONATAL 4 0.0435
30 EPILEPTIC ENCEPHALOPATHY 9 0.0404
31 PAROXYSMAL SYMPATHETIC HYPERACTIVITY 3 0.0400
32 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 18 0.0385
33 MEDICAL DEVICE BATTERY REPLACEMENT 5 0.0370
34 FLUOROSIS 3 0.0349
35 ANTICONVULSANT DRUG LEVEL INCREASED 55 0.0340
36 ANTICOAGULATION DRUG LEVEL DECREASED 4 0.0331
37 STATUS EPILEPTICUS 350 0.0310
38 FOCAL DYSCOGNITIVE SEIZURES 35 0.0307
39 MYOCLONIC EPILEPSY 44 0.0290
40 TONIC CONVULSION 39 0.0275
41 MITRAL VALVE THICKENING 8 0.0268
42 CHANGE IN SEIZURE PRESENTATION 17 0.0263
43 IRON METABOLISM DISORDER 3 0.0252
44 PRODUCT ADMINISTRATION ISSUE 5 0.0239
45 CLONIC CONVULSION 17 0.0232
46 DRUG WITHDRAWAL CONVULSIONS 41 0.0230
47 PARTIAL SEIZURES 118 0.0225
48 RETINOGRAM ABNORMAL 6 0.0224
49 IIIRD NERVE DISORDER 3 0.0211
50 EXCESSIVE EYE BLINKING 31 0.0210
51 PORIOMANIA 4 0.0209
52 DROP ATTACKS 12 0.0202
53 EPILEPTIC AURA 5 0.0194
54 HYPERHOMOCYSTEINAEMIA 5 0.0191
55 ZINC DEFICIENCY 4 0.0186
56 MELAS SYNDROME 4 0.0185
57 CONGENITAL DIAPHRAGMATIC HERNIA 7 0.0179
58 LENNOX-GASTAUT SYNDROME 4 0.0176
59 NEAR DROWNING 3 0.0171
60 PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0167
61 VITAMIN B6 DEFICIENCY 4 0.0163
62 PETIT MAL EPILEPSY 83 0.0162
63 GAZE PALSY 26 0.0152
64 LIPIDS ABNORMAL 10 0.0138
65 HALLUCINATION, OLFACTORY 6 0.0138
66 ARTICULAR CALCIFICATION 3 0.0134
67 HOMICIDAL IDEATION 54 0.0133
68 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 4 0.0129
69 PROPOFOL INFUSION SYNDROME 9 0.0128
70 PHYSICAL ASSAULT 26 0.0124
71 SCHIZOPHRENIFORM DISORDER 3 0.0123
72 EPILEPSY 377 0.0123
73 AMNESTIC DISORDER 6 0.0123
74 NEONATAL SEIZURE 3 0.0120
75 INTELLECTUAL DISABILITY 18 0.0118
76 PSYCHOGENIC SEIZURE 11 0.0118
77 HYPERAMMONAEMIC ENCEPHALOPATHY 20 0.0115
78 DROWNING 11 0.0109
79 GENERALISED TONIC-CLONIC SEIZURE 180 0.0109
80 HYPERAMMONAEMIA 54 0.0108
81 AURA 20 0.0107
82 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 8 0.0106
83 GASTROSCHISIS 5 0.0105
84 SELF-DESTRUCTIVE BEHAVIOUR 9 0.0103
85 CARDIOVASCULAR SYMPTOM 4 0.0103
86 WRONG PATIENT RECEIVED PRODUCT 30 0.0102
87 HOSTILITY 26 0.0102
88 BLINDNESS CORTICAL 5 0.0102
89 SEIZURE 1171 0.0101
90 AGGRESSION 504 0.0101
91 AMMONIA ABNORMAL 4 0.0099
92 BEHAVIOUR DISORDER 53 0.0098
93 ABDOMINAL COMPARTMENT SYNDROME 6 0.0094
94 CEREBELLAR ATAXIA 9 0.0094
95 ACUTE LUNG INJURY 11 0.0093
96 AUTOMATISM 2 0.0093
97 QUADRIPARESIS 15 0.0090
98 PULMONARY HYPOPLASIA 7 0.0089
99 PSYCHOTIC BEHAVIOUR 9 0.0089
100 SIMPLE PARTIAL SEIZURES 7 0.0087
101 SEXUALLY INAPPROPRIATE BEHAVIOUR 4 0.0086
102 ANTICONVULSANT DRUG LEVEL DECREASED 12 0.0085
103 DAYDREAMING 13 0.0084
104 POSTURE ABNORMAL 27 0.0083
105 HYPERNATRAEMIA 41 0.0082
106 PULMONARY VALVE INCOMPETENCE 12 0.0082
107 ATAXIA 97 0.0082
108 PSYCHOMOTOR SKILLS IMPAIRED 20 0.0076
109 ENCEPHALITIS AUTOIMMUNE 10 0.0076
110 DROPPED HEAD SYNDROME 3 0.0076
111 ELECTROENCEPHALOGRAM ABNORMAL 24 0.0076
112 MUSCLE CONTRACTURE 15 0.0074
113 MACROGLOSSIA 4 0.0073
114 DELUSIONAL PERCEPTION 3 0.0072
115 PERSECUTORY DELUSION 18 0.0072
116 GASTROSTOMY 11 0.0071
117 VITAL FUNCTIONS ABNORMAL 6 0.0070
118 BELLIGERENCE 3 0.0070
119 CRANIOCEREBRAL INJURY 21 0.0069
120 IMPULSE-CONTROL DISORDER 14 0.0068
121 HEPATORENAL FAILURE 4 0.0066
122 NEURODEGENERATIVE DISORDER 4 0.0065
123 NEUROLOGICAL DECOMPENSATION 15 0.0065
124 ACUTE PSYCHOSIS 16 0.0065
125 ECHOCARDIOGRAM ABNORMAL 9 0.0064
126 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 17 0.0064
127 PERIPHERAL SENSORIMOTOR NEUROPATHY 8 0.0064
128 MITRAL VALVE DISEASE 11 0.0062
129 SLOW RESPONSE TO STIMULI 8 0.0062
130 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 4 0.0062
131 BRAIN OPERATION 14 0.0061
132 VERBAL ABUSE 3 0.0061
133 INTESTINAL DILATATION 8 0.0060
134 PO2 INCREASED 3 0.0059
135 PNEUMONIA PSEUDOMONAL 9 0.0059
136 LEARNING DISORDER 14 0.0058
137 POSTICTAL STATE 6 0.0058
138 PROCEDURAL SITE REACTION 3 0.0057
139 FOOD REFUSAL 5 0.0057
140 CEREBELLAR ATROPHY 5 0.0057
141 FUNGAL OESOPHAGITIS 4 0.0057
142 SKULL FRACTURE 9 0.0055
143 OTITIS MEDIA 18 0.0054
144 COMPLEX PARTIAL SEIZURES 6 0.0054
145 REPETITIVE SPEECH 3 0.0053
146 PRECOCIOUS PUBERTY 3 0.0053
147 TRACHEITIS 4 0.0052
148 LABILE BLOOD PRESSURE 6 0.0051
149 DRUG RESISTANCE 129 0.0050
150 FEBRILE CONVULSION 6 0.0049
151 ANHIDROSIS 2 0.0049
152 PSYCHOTIC DISORDER 137 0.0046
153 CEREBELLAR SYNDROME 10 0.0046
154 VASOSPASM 4 0.0044
155 GENITAL SWELLING 3 0.0043
156 PNEUMONIA ASPIRATION 108 0.0043
157 THROMBOPHLEBITIS 15 0.0043
158 DRUG TOLERANCE DECREASED 12 0.0043
159 SUSPICIOUSNESS 3 0.0043
160 ANGER 144 0.0043
161 ALTERED STATE OF CONSCIOUSNESS 92 0.0042
162 URINE OUTPUT INCREASED 11 0.0042
163 IRRITABILITY 253 0.0042
164 TRYPTASE INCREASED 3 0.0042
165 WRONG SCHEDULE 4 0.0042
166 TRACHEOSTOMY 6 0.0042
167 UPPER RESPIRATORY TRACT INFLAMMATION 5 0.0042
168 DISSOCIATIVE DISORDER 3 0.0042
169 INFANTILE SPASMS 3 0.0041
170 LAZINESS 7 0.0041
171 RESPIRATORY TRACT OEDEMA 3 0.0040
172 MUCOSAL DISORDER 4 0.0040
173 TRICUSPID VALVE INCOMPETENCE 32 0.0040
174 AORTIC VALVE INCOMPETENCE 17 0.0040
175 VIOLENCE-RELATED SYMPTOM 6 0.0039
176 BODY TEMPERATURE FLUCTUATION 8 0.0038
177 DRUG LEVEL DECREASED 39 0.0038
178 CROUP INFECTIOUS 3 0.0038
179 METAMORPHOPSIA 7 0.0038
180 SLOW SPEECH 9 0.0037
181 LANGUAGE DISORDER 8 0.0037
182 HYPOVENTILATION 12 0.0037
183 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 4 0.0036
184 FACIAL BONES FRACTURE 13 0.0036
185 NYSTAGMUS 19 0.0036
186 SEDATION COMPLICATION 9 0.0035
187 SOLILOQUY 3 0.0035
188 SUICIDE ATTEMPT 208 0.0034
189 RED MAN SYNDROME 3 0.0034
190 THERAPEUTIC PRODUCT CROSS-REACTIVITY 3 0.0034
191 OBSESSIVE THOUGHTS 6 0.0033
192 SELECTIVE EATING DISORDER 3 0.0033
193 CLUMSINESS 9 0.0033
194 PATENT DUCTUS ARTERIOSUS 13 0.0033
195 HAND FRACTURE 23 0.0032
196 HALLUCINATION, AUDITORY 51 0.0032
197 SELF-MEDICATION 13 0.0032
198 NECROTISING COLITIS 4 0.0032
199 ANTICHOLINERGIC SYNDROME 5 0.0031
200 SCREAMING 20 0.0031
201 STUPOR 10 0.0031
202 DRUG TITRATION ERROR 8 0.0031
203 NEGATIVE THOUGHTS 9 0.0031
204 SPUTUM RETENTION 3 0.0030
205 MYOCLONUS 36 0.0030
206 PERSONALITY CHANGE 28 0.0030
207 PRESCRIBED UNDERDOSE 60 0.0030
208 MITRAL VALVE PROLAPSE 5 0.0030
209 ANTISOCIAL BEHAVIOUR 3 0.0030
210 PSYCHIATRIC SYMPTOM 22 0.0030
211 PRESCRIBED OVERDOSE 57 0.0029
212 ABNORMAL BEHAVIOUR 116 0.0029
213 MATERNAL EXPOSURE BEFORE PREGNANCY 20 0.0029
214 ALVEOLITIS ALLERGIC 3 0.0029
215 RHINOVIRUS INFECTION 11 0.0028
216 FEELING DRUNK 21 0.0028
217 COMA SCALE ABNORMAL 8 0.0028
218 COGNITIVE DISORDER 128 0.0027
219 PHYSICAL DECONDITIONING 7 0.0027
220 AORTIC DILATATION 3 0.0027
221 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
222 IMPULSIVE BEHAVIOUR 10 0.0027
223 DYSARTHRIA 99 0.0026
224 SOMNOLENCE 525 0.0026
225 FOLATE DEFICIENCY 3 0.0026
226 HYPOCHLORAEMIA 3 0.0026
227 INHIBITORY DRUG INTERACTION 4 0.0025
228 INTENTIONAL OVERDOSE 162 0.0025
229 INAPPROPRIATE AFFECT 4 0.0025
230 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 17 0.0025
231 PRETERM PREMATURE RUPTURE OF MEMBRANES 3 0.0025
232 DROOLING 17 0.0025
233 PSYCHOTIC SYMPTOM 5 0.0024
234 SEBORRHOEIC DERMATITIS 4 0.0024
235 DRUG LEVEL INCREASED 40 0.0024
236 PSYCHOMOTOR HYPERACTIVITY 40 0.0024
237 HYPOTONIA 24 0.0024
238 SALIVARY HYPERSECRETION 24 0.0024
239 HEPATORENAL SYNDROME 4 0.0024
240 AMMONIA INCREASED 12 0.0023
241 GLIOBLASTOMA 4 0.0023
242 GINGIVAL DISORDER 9 0.0023
243 APGAR SCORE LOW 3 0.0023
244 AGITATION 171 0.0023
245 MIXED LIVER INJURY 7 0.0023
246 ENCEPHALOPATHY 57 0.0023
247 JAW FRACTURE 5 0.0023
248 ALOPECIA AREATA 4 0.0023
249 CEREBRAL ATROPHY 9 0.0023
250 SUICIDAL IDEATION 205 0.0022
251 JOINT ARTHROPLASTY 4 0.0022
252 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0022
253 IDIOPATHIC INTRACRANIAL HYPERTENSION 5 0.0022
254 MATERNAL EXPOSURE DURING BREAST FEEDING 9 0.0022
255 REBOUND EFFECT 25 0.0022
256 ANEURYSM RUPTURED 2 0.0022
257 MYDRIASIS 28 0.0022
258 AFFECT LABILITY 21 0.0022
259 HEAD TITUBATION 3 0.0022
260 SEDATION 57 0.0022
261 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 56 0.0022
262 ABULIA 2 0.0022
263 DRUG INTERACTION 343 0.0022
264 SELF-INJURIOUS IDEATION 9 0.0021
265 DELUSION 33 0.0021
266 INTENSIVE CARE 3 0.0021
267 HYPOPROTEINAEMIA 4 0.0021
268 FACE INJURY 8 0.0021
269 CATATONIA 11 0.0021
270 MOOD ALTERED 57 0.0021
271 HALLUCINATION, VISUAL 44 0.0021
272 STARING 5 0.0021
273 ENCEPHALITIS 14 0.0020
274 CELL DEATH 4 0.0020
275 GASTROINTESTINAL TUBE INSERTION 5 0.0020
276 MARASMUS 3 0.0020
277 SINUS ARREST 3 0.0019
278 WALKING DISABILITY 4 0.0019
279 AFFECTIVE DISORDER 15 0.0019
280 HYPOTHERMIA 19 0.0019
281 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 102 0.0019
282 BRADYPNOEA 5 0.0019
283 SPUTUM INCREASED 4 0.0018
284 TIC 10 0.0018
285 DEAFNESS NEUROSENSORY 6 0.0018
286 PRODUCT SUPPLY ISSUE 13 0.0018
287 ATRIOVENTRICULAR BLOCK 14 0.0018
288 ILEUS PARALYTIC 8 0.0018
289 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
290 ACUTE PULMONARY OEDEMA 10 0.0018
291 DYSPHORIA 9 0.0018
292 GASTROINTESTINAL HYPOMOTILITY 4 0.0018
293 SLEEP TALKING 3 0.0018
294 SPEECH DISORDER DEVELOPMENTAL 5 0.0017
295 PARANOIA 30 0.0017
296 PRIAPISM 6 0.0017
297 ENURESIS 7 0.0017
298 INTENTIONAL SELF-INJURY 35 0.0017
299 ERYTHEMA MULTIFORME 16 0.0017
300 RESPIRATORY DEPRESSION 21 0.0017
301 DRUG ERUPTION 30 0.0017
302 PRODUCT PREPARATION ISSUE 11 0.0017
303 APNOEA 13 0.0017
304 ATRIOVENTRICULAR BLOCK SECOND DEGREE 5 0.0016
305 HYPERSEXUALITY 3 0.0016
306 VITAMIN D DEFICIENCY 16 0.0016
307 SELF INJURIOUS BEHAVIOUR 5 0.0016
308 SINUS NODE DYSFUNCTION 3 0.0016
309 LYMPH NODE PAIN 3 0.0016
310 URINARY TRACT INFECTION BACTERIAL 4 0.0016
311 CLAVICLE FRACTURE 6 0.0016
312 INCREASED BRONCHIAL SECRETION 4 0.0016
313 THERMAL BURN 11 0.0015
314 PYELONEPHRITIS ACUTE 3 0.0015
315 PERSONALITY DISORDER 4 0.0015
316 DISTURBANCE IN ATTENTION 82 0.0015
317 FOOD CRAVING 8 0.0015
318 DEPRESSED LEVEL OF CONSCIOUSNESS 60 0.0015
319 HYPONATRAEMIA 85 0.0015
320 MITRAL VALVE INCOMPETENCE 17 0.0015
321 APHASIA 45 0.0015
322 ANAESTHETIC COMPLICATION 4 0.0015
323 ORGAN FAILURE 6 0.0015
324 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0015
325 LIBIDO INCREASED 3 0.0015
326 THERAPY PARTIAL RESPONDER 23 0.0015
327 CHOLANGITIS SCLEROSING 3 0.0015
328 HYPOPNOEA 5 0.0014
329 HYPERTRANSAMINASAEMIA 10 0.0014
330 BALANCE DISORDER 124 0.0014
331 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
332 DEPRESSIVE SYMPTOM 5 0.0014
333 HYPERKINESIA 3 0.0014
334 FACIAL PARESIS 5 0.0014
335 DELIRIUM 49 0.0014
336 PULMONARY HAEMORRHAGE 11 0.0014
337 OCCUPATIONAL EXPOSURE TO PRODUCT 9 0.0014
338 HYPERTONIA 8 0.0014
339 HYPERSOMNIA 40 0.0014
340 DEREALISATION 3 0.0014
341 RESTLESSNESS 51 0.0014
342 SPEECH DISORDER 73 0.0014
343 ABORTION INDUCED 13 0.0014
344 IMMOBILE 6 0.0014
345 MIOSIS 11 0.0014
346 HALLUCINATION 103 0.0014
347 APRAXIA 2 0.0013
348 DECUBITUS ULCER 11 0.0013
349 POLYNEUROPATHY 16 0.0013
350 COAGULOPATHY 22 0.0013
351 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
352 SCOLIOSIS 8 0.0013
353 SKIN LACERATION 14 0.0013
354 DISORIENTATION 51 0.0013
355 EUPHORIC MOOD 13 0.0013
356 BRAIN OEDEMA 16 0.0013
357 EXPOSURE DURING PREGNANCY 78 0.0013
358 BRADYPHRENIA 8 0.0012
359 BLOOD PRESSURE SYSTOLIC ABNORMAL 3 0.0012
360 DRUG-INDUCED LIVER INJURY 38 0.0012
361 UNRESPONSIVE TO STIMULI 31 0.0012
362 HEAD INJURY 38 0.0012
363 DIPLOPIA 31 0.0012
364 CEREBRAL HAEMATOMA 4 0.0012
365 HALLUCINATIONS, MIXED 5 0.0012
366 BRAIN ABSCESS 3 0.0012
367 GAIT DISTURBANCE 226 0.0012
368 THERAPY NON-RESPONDER 53 0.0012
369 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
370 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
371 MOOD SWINGS 37 0.0012
372 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
373 TOOTH INJURY 5 0.0012
374 ACCIDENTAL OVERDOSE 42 0.0011
375 DEPRESSED MOOD 60 0.0011
376 MYOCARDITIS 13 0.0011
377 COMA 54 0.0011
378 AREFLEXIA 3 0.0011
379 TREATMENT FAILURE 93 0.0011
380 APPARENT DEATH 4 0.0011
381 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
382 ABORTION SPONTANEOUS 44 0.0011
383 APATHY 16 0.0011
384 BRADYCARDIA 58 0.0011
385 FOOD INTOLERANCE 4 0.0011
386 BRAIN FOG 17 0.0011
387 DYSTONIA 21 0.0011
388 CEREBRAL DISORDER 8 0.0011
389 LEUKOENCEPHALOPATHY 4 0.0011
390 LUNG CONSOLIDATION 3 0.0011
391 HEPATIC FUNCTION ABNORMAL 40 0.0011
392 ENDOTRACHEAL INTUBATION 3 0.0011
393 PSYCHOMOTOR RETARDATION 3 0.0011
394 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
395 CATHETER SITE INFECTION 4 0.0011
396 VENTRICULAR SEPTAL DEFECT 6 0.0010
397 COMMUNICATION DISORDER 4 0.0010
398 PARKINSONISM 10 0.0010
399 EYE MOVEMENT DISORDER 7 0.0010
400 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
401 STRIDOR 3 0.0010
402 MENTAL DISORDER 44 0.0010
403 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
404 DYSKINESIA 41 0.0010
405 SMALL FOR DATES BABY 5 0.0010
406 EXPOSURE VIA BREAST MILK 4 0.0010
407 BRAIN HERNIATION 3 0.0010
408 EYE INJURY 3 0.0010
409 IRON DEFICIENCY ANAEMIA 9 0.0010
410 HYPERURICAEMIA 4 0.0010
411 FAMILY STRESS 3 0.0010
412 RESPIRATORY RATE DECREASED 3 0.0010
413 MATERNAL EXPOSURE DURING PREGNANCY 85 0.0010
414 TREATMENT NONCOMPLIANCE 52 0.0009
415 OFF LABEL USE 830 0.0009
416 MEMORY IMPAIRMENT 130 0.0009
417 HEMIPARESIS 16 0.0009
418 PREMATURE DELIVERY 15 0.0009
419 LOSS OF THERAPEUTIC RESPONSE 3 0.0009
420 COORDINATION ABNORMAL 13 0.0009
421 SKIN EROSION 3 0.0009
422 LIVER FUNCTION TEST ABNORMAL 27 0.0009
423 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
424 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
425 NORMAL NEWBORN 5 0.0009
426 RESPIRATORY FAILURE 67 0.0009
427 ASPIRATION 10 0.0009
428 MUSCLE TWITCHING 21 0.0009
429 AUTISM SPECTRUM DISORDER 5 0.0009
430 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
431 ADVERSE REACTION 12 0.0009
432 HYPOPHAGIA 23 0.0009
433 HYPOCALCAEMIA 17 0.0009
434 ANXIETY DISORDER 3 0.0009
435 QUALITY OF LIFE DECREASED 12 0.0009
436 FEAR 24 0.0009
437 PRODUCT USE IN UNAPPROVED INDICATION 220 0.0009
438 ILEUS 11 0.0009
439 CARDIAC VALVE DISEASE 5 0.0009
440 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
441 BRAIN NEOPLASM 8 0.0009
442 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
443 PREMATURE BABY 26 0.0009
444 PERFORMANCE STATUS DECREASED 4 0.0009
445 DRUG INEFFECTIVE 1129 0.0009
446 EOSINOPHILIA 15 0.0009
447 STEVENS-JOHNSON SYNDROME 19 0.0009
448 EMBOLIC STROKE 3 0.0009
449 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
450 BRADYKINESIA 5 0.0008
451 RESPIRATORY TRACT INFECTION 22 0.0008
452 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
453 URINARY RETENTION 28 0.0008
454 SUBDURAL HAEMATOMA 12 0.0008
455 GAIT INABILITY 28 0.0008
456 FOETAL EXPOSURE DURING PREGNANCY 68 0.0008
457 TOXICITY TO VARIOUS AGENTS 139 0.0008
458 DIZZINESS 408 0.0008
459 CONDITION AGGRAVATED 247 0.0008
460 EMOTIONAL DISORDER 25 0.0008
461 RASH MACULO-PAPULAR 18 0.0008
462 TREMOR 134 0.0008
463 HYPERACUSIS 3 0.0008
464 ACUTE HEPATIC FAILURE 11 0.0008
465 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
466 CRYING 29 0.0008
467 JOINT INJURY 17 0.0008
468 TOXIC SKIN ERUPTION 8 0.0008
469 HOSPITALISATION 122 0.0008
470 TOXIC ENCEPHALOPATHY 4 0.0008
471 HYPERTHERMIA 6 0.0008
472 MOTOR DYSFUNCTION 8 0.0008
473 NEOPLASM 9 0.0008
474 LETHARGY 45 0.0008
475 CHOLESTASIS 15 0.0008
476 FEMORAL NECK FRACTURE 4 0.0008
477 INITIAL INSOMNIA 8 0.0008
478 CAESAREAN SECTION 9 0.0008
479 VENTRICULAR EXTRASYSTOLES 8 0.0008
480 RESPIRATORY ACIDOSIS 3 0.0008
481 VERTIGO 46 0.0008
482 LEARNING DISABILITY 4 0.0008
483 METABOLIC ACIDOSIS 24 0.0007
484 LOSS OF CONSCIOUSNESS 96 0.0007
485 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
486 FRUSTRATION TOLERANCE DECREASED 6 0.0007
487 PRODUCT ADMINISTRATION ERROR 15 0.0007
488 SLEEP APNOEA SYNDROME 14 0.0007
489 FALL 244 0.0007
490 MANIA 12 0.0007
491 OSTEOPENIA 11 0.0007
492 SUICIDAL BEHAVIOUR 3 0.0007
493 TRANSAMINASES INCREASED 16 0.0007
494 ERECTION INCREASED 3 0.0007
495 DISEASE RECURRENCE 34 0.0007
496 THERAPY CHANGE 7 0.0007
497 PANCREATITIS ACUTE 16 0.0007
498 DISABILITY 14 0.0007
499 SINUS TACHYCARDIA 10 0.0007
500 MENTAL IMPAIRMENT 17 0.0007
501 PRODUCT USE ISSUE 130 0.0007
502 OBESITY 11 0.0007
503 ORTHOSTATIC HYPOTENSION 12 0.0007
504 FRACTURE 13 0.0007
505 SLUGGISHNESS 7 0.0007
506 OVERDOSE 148 0.0007
507 AMNESIA 44 0.0007
508 ACUTE RESPIRATORY FAILURE 13 0.0007
509 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 48 0.0007
510 WEIGHT INCREASED 151 0.0007
511 HAEMORRHAGE INTRACRANIAL 10 0.0007
512 DEVELOPMENTAL DELAY 6 0.0007
513 SUDDEN DEATH 7 0.0007
514 THERAPEUTIC RESPONSE DECREASED 40 0.0007
515 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
516 DECREASED APPETITE 151 0.0006
517 CONCUSSION 5 0.0006
518 SEPTIC SHOCK 28 0.0006
519 TIBIA FRACTURE 3 0.0006
520 BLEPHAROSPASM 4 0.0006
521 SKIN ABRASION 3 0.0006
522 PHOTOPSIA 4 0.0006
523 NEPHROLITHIASIS 29 0.0006
524 DRUG INTOLERANCE 61 0.0006
525 HYPERGLYCAEMIA 23 0.0006
526 PROTEINURIA 12 0.0006
527 FUNGAL INFECTION 21 0.0006
528 HEPATIC CYTOLYSIS 8 0.0006
529 ERECTILE DYSFUNCTION 16 0.0006
530 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
531 OXYGEN SATURATION DECREASED 35 0.0006
532 HUMERUS FRACTURE 3 0.0006
533 MYASTHENIA GRAVIS 5 0.0006
534 INCOHERENT 4 0.0006
535 HYPERPROLACTINAEMIA 4 0.0006
536 ASPHYXIA 5 0.0006
537 SOMNAMBULISM 4 0.0006
538 HYPOGAMMAGLOBULINAEMIA 4 0.0006
539 NERVOUS SYSTEM DISORDER 19 0.0006
540 GASTRITIS 16 0.0006
541 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
542 RESPIRATORY DISORDER 18 0.0006
543 EAR INFECTION 16 0.0006
544 CONFUSIONAL STATE 97 0.0006
545 ATRIAL SEPTAL DEFECT 5 0.0006
546 BACTERAEMIA 7 0.0006
547 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
548 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
549 DEPRESSION 132 0.0006
550 FAILURE TO THRIVE 3 0.0006
551 MENTAL STATUS CHANGES 16 0.0006
552 HEART RATE IRREGULAR 13 0.0006
553 THROMBOCYTOPENIA 64 0.0006
554 BLOOD LACTIC ACID INCREASED 3 0.0006
555 INCONTINENCE 6 0.0006
556 JOINT DISLOCATION 6 0.0006
557 HYPERCALCAEMIA 7 0.0006
558 HEPATOCELLULAR INJURY 8 0.0006
559 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
560 RESPIRATORY RATE INCREASED 5 0.0006
561 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
562 LIVER FUNCTION TEST INCREASED 12 0.0006
563 SECRETION DISCHARGE 7 0.0006
564 HEPATIC ENZYME INCREASED 38 0.0006
565 BRUXISM 3 0.0006
566 HIP SURGERY 3 0.0006
567 VISUAL FIELD DEFECT 4 0.0006
568 TOOTH FRACTURE 6 0.0005
569 INTERMENSTRUAL BLEEDING 3 0.0005
570 SLEEP DISORDER 37 0.0005
571 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
572 SHOCK 12 0.0005
573 LOWER LIMB FRACTURE 10 0.0005
574 NIGHTMARE 18 0.0005
575 FEMUR FRACTURE 16 0.0005
576 POOR QUALITY SLEEP 11 0.0005
577 RENAL TUBULAR NECROSIS 5 0.0005
578 UNDERDOSE 37 0.0005
579 PNEUMONIA 164 0.0005
580 URINARY INCONTINENCE 15 0.0005
581 BLOOD IRON DECREASED 6 0.0005
582 PRODUCT PRESCRIBING ISSUE 11 0.0005
583 RHABDOMYOLYSIS 21 0.0005
584 CEREBRAL INFARCTION 12 0.0005
585 CARDIOGENIC SHOCK 7 0.0005
586 CARDIAC ARREST 40 0.0005
587 GENERAL PHYSICAL HEALTH DETERIORATION 56 0.0005
588 SPINAL COMPRESSION FRACTURE 4 0.0005
589 POOR VENOUS ACCESS 5 0.0005
590 MENSTRUAL DISORDER 4 0.0005
591 HEMIPLEGIA 4 0.0005
592 DYSSTASIA 14 0.0005
593 WEIGHT DECREASED 131 0.0005
594 LEUKOPENIA 23 0.0005
595 BLOOD PRESSURE FLUCTUATION 11 0.0005
596 INSURANCE ISSUE 7 0.0005
597 URINE OUTPUT DECREASED 4 0.0005
598 INTENTIONAL PRODUCT USE ISSUE 40 0.0005
599 BEDRIDDEN 6 0.0005
600 GRIP STRENGTH DECREASED 4 0.0005
601 MENINGITIS 3 0.0004
602 COLITIS ISCHAEMIC 3 0.0004
603 PRODUCT LABEL ISSUE 3 0.0004
604 SENSORY DISTURBANCE 7 0.0004
605 HYPOKALAEMIA 20 0.0004
606 ANXIETY 123 0.0004
607 PRODUCT DISTRIBUTION ISSUE 4 0.0004
608 HEPATIC FAILURE 13 0.0004
609 THINKING ABNORMAL 8 0.0004
610 COVID-19 PNEUMONIA 5 0.0004
611 EATING DISORDER 9 0.0004
612 NERVOUSNESS 22 0.0004
613 PARALYSIS 6 0.0004
614 TACHYCARDIA 37 0.0004
615 DEEP VEIN THROMBOSIS 27 0.0004
616 DERMATITIS BULLOUS 3 0.0004
617 HYPOTENSION 83 0.0004
618 HYPOKINESIA 6 0.0004
619 DIZZINESS POSTURAL 4 0.0004
620 PANIC ATTACK 15 0.0004
621 SCHIZOPHRENIA 5 0.0004
622 PHARYNGEAL SWELLING 4 0.0004
623 CARDIO-RESPIRATORY ARREST 17 0.0004
624 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
625 FATIGUE 316 0.0004
626 PYREXIA 140 0.0004
627 LIGAMENT SPRAIN 4 0.0004
628 INABILITY TO AFFORD MEDICATION 4 0.0004
629 KETOACIDOSIS 3 0.0004
630 ADVERSE DRUG REACTION 36 0.0004
631 ILLNESS 41 0.0004
632 POISONING 5 0.0004
633 PRODUCT AVAILABILITY ISSUE 9 0.0004
634 MUSCLE ATROPHY 5 0.0004
635 INSOMNIA 105 0.0004
636 HAEMODYNAMIC INSTABILITY 3 0.0004
637 URINARY TRACT INFECTION 67 0.0004
638 ADVERSE EVENT 36 0.0004
639 TARDIVE DYSKINESIA 11 0.0004
640 HYPOALBUMINAEMIA 3 0.0004
641 PELVIC FRACTURE 3 0.0004
642 FURUNCLE 3 0.0004
643 LOW BIRTH WEIGHT BABY 3 0.0004
644 MUSCULOSKELETAL STIFFNESS 33 0.0004
645 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
646 MOVEMENT DISORDER 12 0.0004
647 HEREDITARY ANGIOEDEMA 4 0.0004
648 BLOOD SODIUM DECREASED 7 0.0004
649 DECREASED ACTIVITY 4 0.0004
650 FOOT FRACTURE 7 0.0004
651 HYPOXIA 13 0.0004
652 DYSPHAGIA 35 0.0004
653 SHOCK HAEMORRHAGIC 3 0.0004
654 BIPOLAR DISORDER 4 0.0004
655 INCREASED APPETITE 7 0.0004
656 INTENTIONAL PRODUCT MISUSE 32 0.0004
657 WOUND INFECTION 4 0.0004
658 RESPIRATORY ARREST 10 0.0004
659 DENTAL CARIES 4 0.0004
660 PRODUCT DOSE OMISSION ISSUE 106 0.0004
661 EOSINOPHIL COUNT INCREASED 3 0.0004
662 MEDICATION ERROR 20 0.0004
663 DRUG EFFECT INCOMPLETE 13 0.0004
664 MALNUTRITION 4 0.0004
665 NEPHROPATHY TOXIC 4 0.0004
666 SEASONAL ALLERGY 5 0.0004
667 PRODUCT CONTAINER ISSUE 3 0.0003
668 PSEUDOMONAS INFECTION 3 0.0003
669 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
670 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
671 GASTROENTERITIS 5 0.0003
672 SPLENOMEGALY 4 0.0003
673 VOMITING 158 0.0003
674 PRODUCT PRESCRIBING ERROR 8 0.0003
675 THERAPY INTERRUPTED 24 0.0003
676 ACCIDENT 4 0.0003
677 ROAD TRAFFIC ACCIDENT 14 0.0003
678 EYE DISORDER 11 0.0003
679 ANAL INCONTINENCE 3 0.0003
680 RASH 145 0.0003
681 GASTROENTERITIS VIRAL 6 0.0003
682 OROPHARYNGEAL DISCOMFORT 3 0.0003
683 VIRAL INFECTION 11 0.0003
684 HYPOGLYCAEMIA 16 0.0003
685 PNEUMONIA BACTERIAL 3 0.0003
686 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
687 EJECTION FRACTION DECREASED 5 0.0003
688 BACTERIAL INFECTION 6 0.0003
689 HEPATIC ENCEPHALOPATHY 3 0.0003
690 HAEMATURIA 11 0.0003
691 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
692 DERMATITIS ALLERGIC 4 0.0003
693 CYANOSIS 5 0.0003
694 RECALLED PRODUCT ADMINISTERED 3 0.0003
695 HEPATITIS 8 0.0003
696 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
697 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
698 SINUS BRADYCARDIA 3 0.0003
699 HAEMATOMA 8 0.0003
700 THROMBOTIC MICROANGIOPATHY 3 0.0003
701 COELIAC DISEASE 3 0.0003
702 INFLUENZA 34 0.0003
703 BODY TEMPERATURE DECREASED 3 0.0003
704 VENTRICULAR TACHYCARDIA 5 0.0003
705 SOPOR 4 0.0003
706 APPETITE DISORDER 2 0.0003
707 VISUAL ACUITY REDUCED 10 0.0003
708 CANDIDA INFECTION 5 0.0003
709 SUBARACHNOID HAEMORRHAGE 3 0.0003
710 TACHYPNOEA 4 0.0003
711 RIB FRACTURE 6 0.0003
712 VISION BLURRED 40 0.0003
713 GASTROINTESTINAL DISORDER 26 0.0003
714 HYPERBILIRUBINAEMIA 3 0.0003
715 AUTOIMMUNE HEPATITIS 2 0.0003
716 DISEASE PROGRESSION 34 0.0003
717 LIVER INJURY 7 0.0003
718 AMENORRHOEA 5 0.0003
719 HEART RATE DECREASED 10 0.0003
720 MOUTH ULCERATION 6 0.0003
721 FULL BLOOD COUNT ABNORMAL 3 0.0003
722 RETCHING 6 0.0003
723 ACUTE KIDNEY INJURY 43 0.0003
724 HEADACHE 176 0.0003
725 CEREBRAL HAEMORRHAGE 10 0.0003
726 IMPAIRED QUALITY OF LIFE 4 0.0003
727 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
728 RASH PRURITIC 15 0.0003
729 HAEMATEMESIS 7 0.0003
730 CONSTIPATION 60 0.0003
731 FLUID OVERLOAD 4 0.0003
732 SINUSITIS 28 0.0003
733 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
734 INFECTION 39 0.0003
735 PANCYTOPENIA 15 0.0003
736 MIDDLE INSOMNIA 5 0.0003
737 SKIN INFECTION 3 0.0003
738 OCULAR DISCOMFORT 3 0.0003
739 HYPOAESTHESIA ORAL 4 0.0003
740 COMPLETED SUICIDE 22 0.0003
741 PERICARDIAL EFFUSION 6 0.0003
742 EYELID OEDEMA 3 0.0003
743 APHTHOUS ULCER 2 0.0003
744 BRONCHITIS 19 0.0003
745 SKIN FISSURES 5 0.0003
746 MUSCULAR WEAKNESS 29 0.0003
747 FEELING ABNORMAL 61 0.0003
748 ARRHYTHMIA 12 0.0003
749 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
750 FEELING COLD 7 0.0003
751 SEPSIS 28 0.0003
752 UPPER LIMB FRACTURE 5 0.0003
753 MUSCLE RIGIDITY 3 0.0003
754 ATRIAL FLUTTER 2 0.0003
755 RENAL IMPAIRMENT 21 0.0002
756 DEHYDRATION 33 0.0002
757 BURSITIS 3 0.0002
758 NOCTURIA 3 0.0002
759 MUSCLE TIGHTNESS 4 0.0002
760 FEEDING DISORDER 5 0.0002
761 PANCREATITIS 13 0.0002
762 INTENTIONAL DOSE OMISSION 7 0.0002
763 BODY TEMPERATURE INCREASED 5 0.0002
764 CYST 3 0.0002
765 PULMONARY HYPERTENSION 5 0.0002
766 CONTUSION 23 0.0002
767 BLOOD UREA INCREASED 4 0.0002
768 CELLULITIS 12 0.0002
769 ANAEMIA 45 0.0002
770 NEUTROPENIA 32 0.0002
771 IMPAIRED WORK ABILITY 5 0.0002
772 IRRITABLE BOWEL SYNDROME 5 0.0002
773 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
774 ANURIA 2 0.0002
775 PRODUCT DOSE OMISSION 15 0.0002
776 DIARRHOEA 147 0.0002
777 CONVULSION 13 0.0002
778 LIVER DISORDER 10 0.0002
779 HEPATOTOXICITY 5 0.0002
780 HAIR TEXTURE ABNORMAL 3 0.0002
781 THIRST 4 0.0002
782 ORAL PAIN 5 0.0002
783 SNEEZING 5 0.0002
784 COVID-19 39 0.0002
785 PALLOR 6 0.0002
786 C-REACTIVE PROTEIN INCREASED 8 0.0002
787 HYPOTHYROIDISM 7 0.0002
788 ABNORMAL DREAMS 6 0.0002
789 ORAL DISCOMFORT 3 0.0002
790 HYPERSENSITIVITY 40 0.0002
791 ASTHENIA 81 0.0002
792 DEMENTIA 6 0.0002
793 WITHDRAWAL SYNDROME 9 0.0002
794 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
795 CARDIAC FAILURE 17 0.0002
796 ECZEMA 11 0.0002
797 LIP SWELLING 7 0.0002
798 VISUAL IMPAIRMENT 26 0.0002
799 PRODUCTIVE COUGH 10 0.0002
800 POST PROCEDURAL COMPLICATION 4 0.0002
801 ATELECTASIS 2 0.0002
802 AUTOIMMUNE DISORDER 2 0.0002
803 OEDEMA PERIPHERAL 25 0.0002
804 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
805 ABASIA 5 0.0002
806 HEART RATE INCREASED 20 0.0002
807 PRODUCT PHYSICAL ISSUE 4 0.0002
808 LYMPHADENOPATHY 7 0.0002
809 TASTE DISORDER 4 0.0002
810 NEUTROPHIL COUNT DECREASED 8 0.0002
811 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
812 OSTEOPOROSIS 8 0.0002
813 ANKLE FRACTURE 3 0.0002
814 SYNCOPE 19 0.0002
815 PNEUMOTHORAX 3 0.0002
816 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 34 0.0002
817 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
818 NAUSEA 148 0.0002
819 HYPOACUSIS 8 0.0002
820 HYPERTENSION 39 0.0002
821 RESPIRATORY DISTRESS 5 0.0002
822 RENAL FAILURE 24 0.0002
823 BLOOD PRESSURE DECREASED 12 0.0002
824 TOOTH DISORDER 4 0.0002
825 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
826 MIGRAINE 17 0.0002
827 CIRCULATORY COLLAPSE 3 0.0002
828 METRORRHAGIA 3 0.0002
829 THERAPY CESSATION 9 0.0002
830 TINNITUS 8 0.0002
831 NEUROTOXICITY 3 0.0002
832 INJURY 12 0.0002
833 METASTASES TO LIVER 3 0.0002
834 ACUTE MYOCARDIAL INFARCTION 5 0.0002
835 PLATELET COUNT DECREASED 18 0.0002
836 NASOPHARYNGITIS 31 0.0002
837 TOOTHACHE 3 0.0002
838 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
839 MUSCLE SPASMS 30 0.0002
840 ABNORMAL WEIGHT GAIN 2 0.0002
841 CONJUNCTIVITIS 3 0.0002
842 UNEVALUABLE EVENT 12 0.0002
843 ACNE 12 0.0002
844 GLAUCOMA 3 0.0002
845 EAR PAIN 3 0.0002
846 SKIN DISCOLOURATION 7 0.0002
847 RENAL DISORDER 7 0.0002
848 CYTOKINE RELEASE SYNDROME 3 0.0001
849 MENSTRUATION IRREGULAR 4 0.0001
850 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
851 NO ADVERSE EVENT 27 0.0001
852 STOMATITIS 9 0.0001
853 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
854 OEDEMA 8 0.0001
855 RASH ERYTHEMATOUS 7 0.0001
856 PERITONITIS 3 0.0001
857 DIVERTICULITIS 4 0.0001
858 PROCEDURAL PAIN 4 0.0001
859 DERMATITIS 3 0.0001
860 NECK PAIN 8 0.0001
861 WOUND 4 0.0001
862 HYPERKALAEMIA 5 0.0001
863 HERPES ZOSTER 8 0.0001
864 PRODUCT SUBSTITUTION ISSUE 8 0.0001
865 PRODUCT DISPENSING ERROR 3 0.0001
866 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
867 DRUG WITHDRAWAL SYNDROME 12 0.0001
868 DYSURIA 5 0.0001
869 ABDOMINAL DISTENSION 14 0.0001
870 BLOOD POTASSIUM DECREASED 4 0.0001
871 CHROMATURIA 3 0.0001
872 PLEURAL EFFUSION 8 0.0001
873 DRUG EFFECT DECREASED 7 0.0001
874 LIMB DISCOMFORT 4 0.0001
875 MALAISE 56 0.0001
876 ALOPECIA 25 0.0001
877 HAEMATOCHEZIA 7 0.0001
878 ABSCESS 2 0.0001
879 BLOOD GLUCOSE DECREASED 6 0.0001
880 DIABETIC KETOACIDOSIS 3 0.0001
881 PRESYNCOPE 3 0.0001
882 NEURALGIA 3 0.0001
883 PERIPHERAL SWELLING 19 0.0001
884 DEATH 105 0.0001
885 STAPHYLOCOCCAL INFECTION 4 0.0001
886 INFUSION RELATED REACTION 8 0.0001
887 BACK PAIN 28 0.0001
888 EXPIRED PRODUCT ADMINISTERED 4 0.0001
889 AGEUSIA 3 0.0001
890 DYSPHONIA 7 0.0001
891 URTICARIA 20 0.0001
892 NASAL CONGESTION 7 0.0001
893 OROPHARYNGEAL PAIN 11 0.0001
894 INCORRECT DOSE ADMINISTERED 27 0.0001
895 CEREBROVASCULAR ACCIDENT 20 0.0001
896 ABDOMINAL PAIN UPPER 24 0.0001
897 SKIN ULCER 3 0.0001
898 DEAFNESS 3 0.0001
899 ANHEDONIA 3 0.0001
900 ANGIOEDEMA 5 0.0001
901 JAUNDICE 3 0.0001
902 THROAT TIGHTNESS 3 0.0001
903 LIMB INJURY 3 0.0001
904 PNEUMONITIS 3 0.0001
905 ANAPHYLACTIC REACTION 6 0.0001
906 RHINORRHOEA 7 0.0001
907 FLUSHING 11 0.0001
908 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
909 NEOPLASM MALIGNANT 7 0.0001
910 BLOOD PRESSURE INCREASED 16 0.0001
911 COUGH 29 0.0001
912 ABDOMINAL PAIN 24 0.0001
913 SURGERY 6 0.0001
914 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
915 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
916 LACRIMATION INCREASED 3 0.0001
917 EXTRA DOSE ADMINISTERED 4 0.0001
918 FLUID RETENTION 5 0.0001
919 BLINDNESS 4 0.0001
920 ERYTHEMA 20 0.0001
921 GYNAECOMASTIA 3 0.0001
922 INFLAMMATION 5 0.0001
923 SWELLING 9 0.0001
924 DRUG ABUSE 8 0.0001
925 SWOLLEN TONGUE 3 0.0001
926 POLLAKIURIA 4 0.0001
927 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
928 CYSTITIS 3 0.0001
929 HYPOAESTHESIA 14 0.0001
930 HOT FLUSH 7 0.0001
931 IMPAIRED HEALING 3 0.0001
932 PRURITUS 35 0.0001
933 SKIN DISORDER 3 0.0001
934 BLISTER 5 0.0001
935 PARAESTHESIA 14 0.0001
936 HAEMOGLOBIN DECREASED 9 0.0001
937 DRY MOUTH 7 0.0001
938 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
939 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
940 OCULAR HYPERAEMIA 4 0.0001
941 MULTIPLE SCLEROSIS 4 0.0001
942 MOBILITY DECREASED 6 0.0001
943 ABDOMINAL DISCOMFORT 14 0.0001
944 INTERSTITIAL LUNG DISEASE 4 0.0001
945 ILL-DEFINED DISORDER 5 0.0001
946 EYE SWELLING 3 0.0001
947 EPISTAXIS 6 0.0001
948 INTESTINAL OBSTRUCTION 3 0.0001
949 DYSPNOEA 45 0.0001
950 CHRONIC KIDNEY DISEASE 6 0.0001
951 PAIN IN EXTREMITY 23 0.0001
952 SWELLING FACE 5 0.0001
953 HAEMORRHAGE 8 0.0001
954 CARDIAC FAILURE CONGESTIVE 6 0.0001
955 FLATULENCE 4 0.0001
956 RECTAL HAEMORRHAGE 3 0.0001
957 PAIN 42 0.0001
958 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
959 CHILLS 8 0.0001
960 DYSGEUSIA 5 0.0001
961 COLITIS ULCERATIVE 3 0.0001
962 PULMONARY OEDEMA 3 0.0001
963 THROAT IRRITATION 3 0.0001
964 DRUG DOSE OMISSION 11 0.0001
965 DIABETES MELLITUS 5 0.0001
966 DISCOMFORT 4 0.0001
967 FEELING HOT 4 0.0001
968 BLOOD CHOLESTEROL INCREASED 3 0.0001
969 CARDIAC DISORDER 6 0.0001
970 PULMONARY EMBOLISM 6 0.0001
971 BLOOD CREATININE INCREASED 4 0.0001
972 DYSPEPSIA 6 0.0001
973 ARTHRALGIA 25 0.0001
974 DRY SKIN 8 0.0001
975 JOINT SWELLING 7 0.0001
976 DERMATITIS ATOPIC 3 0.0001
977 EYE PAIN 3 0.0001
978 BLOOD GLUCOSE INCREASED 10 0.0001
979 ATRIAL FIBRILLATION 5 0.0001
980 PALPITATIONS 6 0.0001
981 BONE PAIN 3 0.0001
982 DRUG DEPENDENCE 8 0.0000
983 CHEST DISCOMFORT 5 0.0000
984 CHEST PAIN 9 0.0000
985 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
986 SKIN EXFOLIATION 4 0.0000
987 MYALGIA 8 0.0000
988 ASTHMA 5 0.0000
989 BREAST CANCER 4 0.0000
990 EMOTIONAL DISTRESS 5 0.0000
991 INFLUENZA LIKE ILLNESS 3 0.0000
992 MYOCARDIAL INFARCTION 6 0.0000
993 HYPERHIDROSIS 4 0.0000
994 ARTHRITIS 2 0.0000
995 PRODUCT QUALITY ISSUE 3 0.0000